Overall Status

Recruiting (2)

Enrolling by invitation (1)

Unknown status (1)

Phase

n/a (1)

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Salarius Pharmaceuticals, LLC (2)

Davide Di Santo (1)

Italian Sarcoma Group (1)

Collaborator

National Pediatric Cancer Foundation (1)

Intervention

seclidemstat (2)

clinical evaluation (1)

cyclophosphamide (1)

final histopathological diagnosis (1)

fine needle aspiration cytology (1)

multiparametric magnetic resonance imaging (1)

prospective cohort (1)

randomized cohort (1)

topotecan (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

other (1)

radiation (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (3)

Observational [Patient Registry] (1)

Myoepithelioma

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)

Enrolling by invitation

Ewing Sarcoma
+8 more

Seclidemstat

Santa Monica, California

Sarcoma Oncology Center

Feb 23, 2022

Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)

Recruiting

Ewing Sarcoma
+10 more

Seclidemstat
+2 more

Los Angeles, California
+16 more

Jan 18, 2022

Chordoma Trial in Worldwide (Randomized Cohort, Prospective cohort)

Recruiting

Chordoma

Randomized Cohort
Prospective cohort

Graz, Austria
+27 more

Oct 29, 2021

Parotid Tumor, Parotid Cancer Trial in Milan (Multiparametric Magnetic Resonance Imaging, Fine Needle Aspiration Cytology,

Unknown status

Parotid Neoplasm
Parotid Cancer

Multiparametric Magnetic Resonance Imaging
+3 more

Milan, Italy

IRCCS San Raffaele

Feb 20, 2019